Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial

Gynecologic Oncology

Volumn 127, Issue 3, 2012, Pages 440-450

  Roset Bahmanyar, Edith ^a   Paavonen, Jorma ^b   Naud, Paulo ^c   Salmerón, Jorge ^d   Chow, Song Nan ^e   Apter, Dan ^f   Kitchener, Henry ^g   Castellsagué, Xavier ^h   Teixeira, Julio C ⁱ   Skinner, S Rachel ^j,x   Jaisamrarn, Unnop ^k   Limson, Genara A ^l   Garland, Suzanne M ^m,y,z,aa   Szarewski, Anne ⁿ   Romanowski, Barbara ^o   Aoki, Fred ^p   Schwarz, Tino F ^q   Poppe, Willy A J ^r   De Carvalho, Newton S ^s   Harper, Diane M ^t   Bosch, F Xavier ^h   Raillard, Alice ^u   Descamps, Dominique ^a   Struyf, Frank ^a   Lehtinen, Matti ^v   Dubin, Gary ^w   more..

^a GSK   (Belgium)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f Vaestoliitto   (Finland)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

^h BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

ⁱ UNIVERSITY OF CAMPINAS   (Brazil)

^j UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^k CHULALONGKORN UNIVERSITY   (Thailand)

^l UNIVERSITY OF THE PHILIPPINES   (Philippines)

^m ROYAL WOMEN'S HOSPITAL   (Australia)

ⁿ QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^o UNIVERSITY OF ALBERTA   (Canada)

^p UNIVERSITY OF MANITOBA   (Canada)

^q UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^r UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^s FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^t DARTMOUTH MEDICAL SCHOOL   (United States)

^u 4Clinics ^*  (France)

^v UNIVERSITY OF TAMPERE   (Finland)

^w GLAXOSMITHKLINE   (United States)

^x UNIVERSITY OF SYDNEY   (Australia)

^y ROYAL CHILDREN'S HOSPITAL   (Australia)

^z MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^aa UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

Behavior; Human papillomavirus; Prevalence; Questionnaire; Risk factor

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CONTROLLED STUDY; CYTOLOGY; DISEASE ASSOCIATION; FEMALE; HORMONAL CONTRACEPTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PAPILLOMAVIRUS INFECTION; PHASE 3 CLINICAL TRIAL; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEXUAL INTERCOURSE; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SMOKING; UTERINE CERVIX DISEASE;

ADOLESCENT; ADULT; CERVIX UTERI; FEMALE; HUMANS; LOGISTIC MODELS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; RISK FACTORS; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 84868554266     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.08.033     Document Type: Article

References (62)

1. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, and K.V. Shah Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19
2. V. Bouvard, R. Baan, K. Straif, Y. Grosse, B. Secretan, and F. El Ghissassi A review of human carcinogens - Part B: biological agents Lancet Oncol 10 2009 321 322
3. S. de Sanjosé, W.G.V. Quint, L. Alemany, D.T. Geraets, J.E. Klaustermeier, and B. Lloveras Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional survey Lancet Oncol 11 2010 1048 1056
4. M. Plummer, M. Schiffman, P.E. Castle, D. Maucort-Boulch, and C.M. Wheeler ALTS Group. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion J Infect Dis 195 2007 1582 1589
5. A.B. Moscicki, S. Shiboski, N.K. Hills, K.J. Powell, N. Jay, and E.N. Hanson Regression of low-grade squamous intraepithelial lesions in young women Lancet 364 2004 1678 1683
6. N.F. Schlecht, R.W. Platt, E. Duarte-Franco, M.C. Costa, J.P. Sobrinho, and J.C. Prado Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia J Natl Cancer Inst 95 2003 1336 1343
7. C.M. Wheeler Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer Obstet Gynecol Clin N Am 35 2008 519 536
8. S. Vaccarella, R. Herrero, M. Dai, P.J. Snijders, C.J. Meijer, and J.O. Thomas Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys Cancer Epidemiol Biomarkers Prev 15 2006 2148 2152
9. S. Vaccarella, S. Franceschi, R. Herrero, N. Muñoz, P.J. Snijders, and G.M. Clifford Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys Cancer Epidemiol Biomarkers Prev 15 2006 326 333
10. S. Syrjänen, T. Waterboer, M. Sarkola, K. Michael, M. Rintala, and K. Syrjänen Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy J Gen Virol 90 2009 1515 1526
11. International Collaboration of Epidemiological Studies of Cervical Cancer P. Appleby, V. Beral, A. Berrington de González, D. Colin, and S. Franceschi Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies Int J Cancer 118 2006 1481 1495
12. International Collaboration of Epidemiological Studies of Cervical Cancer Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies Int J Cancer 120 2006 885 891
13. S.C. Cotton, L. Sharp, R. Seth, L.F. Masson, J. Little, and M.E. Cruickshank Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women Br J Cancer 97 2007 133 139
14. D. Maucort-Boulch, M. Plummer, P.E. Castle, F. Demuth, M. Safaeian, and C.M. Wheeler Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology Int J Cancer 126 2010 684 691
15. International Collaboration of Epidemiological Studies of Cervical Cancer Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies Cancer Epidemiol Biomarkers Prev 18 2009 1060 1069
16. A.K. Chaturvedi, M.M. Madeleine, R.J. Biggar, and E.A. Engels Risk of human papillomavirus-associated cancers among persons with AIDS J Natl Cancer Inst 101 2009 1120 1130
17. J.S. Smith, N. Muñoz, R. Herrero, J. Eluf-Neto, C. Ngelangel, and S. Franceschi Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines J Infect Dis 185 2002 324 331
18. J.S. Smith, R. Herrero, C. Bosetti, N. Muñoz, F.X. Bosch, and J. Eluf-Neto Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer J Natl Cancer Inst 94 2002 1604 1613
19. J. Paavonen, D. Jenkins, F.X. Bosch, P. Naud, J. Salmerón, and C.M. Wheeler Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial Lancet 369 2007 2161 2170
20. J. Paavonen, P. Naud, J. Salmerón, C.M. Wheeler, S.N. Chow, and D. Apter Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women Lancet 374 2009 301 314
21. M. Lehtinen, J. Paavonen, C.M. Wheeler, U. Jaisamrarn, S.M. Garland, and X. Castellsagué Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial Lancet Oncol 13 2012 89 99
22. L.-J. van Doorn, A. Molijn, B. Kleter, W. Quint, and B. Colau Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR J Clin Microbiol 44 2006 3292 3298
23. M. Lehtinen, D. Apter, G. Dubin, E. Kosunen, R. Isaksson, and E.L. Korpivaara Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing Int J STD AIDS 17 2006 517 521
24. J.E. Tota, M. Chevarie-Davis, L.A. Richardson, M. deVries, and E.L. Franco Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies Prev Med 53 2011 S12 S21
25. S. Vaccarella, R. Herrero, P.J.F. Snijders, M. Dai, J.O. Thomas, and N.T. Hieu Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys Int J Epidemiol 37 2008 536 546
26. K. Syrjänen, I. Shabalova, N. Petrovichev, V. Kozachenko, T. Zakharova, and J. Pajanidi Smoking is an independent risk factor for oncogenic human papillomavirus (HPV) infections but not for high-grade CIN Eur J Epidemiol 22 2007 723 735
27. J.W. Sellors, J.B. Mahony, J. Kaczorowski, J.B. Mahony, A. Lytwyn, and S. Chong Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group CMAJ 163 2000 503 508
28. R.L. Winer, S.K. Lee, J.P. Hughes, D.E. Adam, N.B. Kiviat, and L.A. Koutsky Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students Am J Epidemiol 157 2003 218 226
29. S. Collins, T.P. Rollason, L.S. Young, and C.B.J. Woodman Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: a longitudinal study Eur J Cancer 46 2010 405 411
30. N. Muñoz, F. Méndez, H. Posso, M. Molano, A.J. van den Brule, and M. Ronderos Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results J Infect Dis 190 2004 2077 2087
31. J.W. Sellors, T.L. Karwalajtys, and J. Kaczorowski Incidence, clearance and predictors of human papillomavirus infection in women CMAJ 168 2003 421 425
32. S.K. Kjaer, A.J. van den Brule, J.E. Bock, P.A. Poll, G. Engholm, and M.E. Sherman Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev 6 1997 799 805
33. A.B. Moscicki, N. Hills, S. Shiboski, K. Powell, N. Jay, and E. Hanson Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females JAMA 285 2001 2995 3002
34. A. Simen-Kapeu, G. La Ruche, V. Kataja, M. Yliskoski, C. Bergeron, and A. Horo Tobacco smoking and chewing as risk factors for multiple human papillomavirus infections and cervical squamous intraepithelial lesions in two countries (Côte d'Ivoire and Finland) with different tobacco exposure Cancer Causes Control 20 2009 163 170
35. V.R. Girianelli, E. Azevedo, G. Silva, and L.C. Thuler Factors associated with the risk of progression to precursor lesions or cervical cancer in women with negative cytologic findings Int J Gynaecol Obstet 107 2009 228 231
36. S.S. Wang, R.E. Zuna, N. Wentzensen, S.T. Dunn, M.E. Sherman, and M.A. Gold Human papillomavirus cofactors by disease progression and human papillomavirus types in the Study to Understand Cervical Cancer Early Endpoints and Determinants Cancer Epidemiol Biomarkers Prev 18 2009 113 120
37. A. Simen-Kapeu, V. Kataja, M. Yliskoski, K. Syrjänen, J. Dillner, and P. Koskela Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection Scand J Infect Dis 40 2008 745 751
38. K. Syrjänen, I. Shabalova, N. Petrovichev, V. Kozachenko, T. Zakharova, and J. Pajanidi Oral contraceptives are not an independent risk factor for cervical intraepithelial neoplasia or high-risk human papillomavirus infections Anticancer Res 26 2006 4729 4740
39. International Collaboration of Epidemiological Studies of Cervical Cancer P. Appleby, V. Beral, A. Berrington de González, D. Colin, and S. Franceschi Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies Lancet 370 2007 1609 1621
40. J.S. Smith, J. Green, A. Berrington de Gonzalez, P. Appleby, J. Peto, and M. Plummer Cervical cancer and use of hormonal contraceptives: a systematic review Lancet 361 2003 1159 1167
41. E.-M. de Villiers Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma Int J Cancer 103 2003 705 708
42. B.T. Hansen, S.K. Kjaer, C. Munk, L. Tryggvadottir, P. Sparén, and M. Hagerup-Jenssen Early smoking initiation, sexual behavior and reproductive health - a large population-based study of Nordic women Prev Med 51 2010 68 72
43. A.M. Johnson, J. Wadsworth, K. Wellings, and J. Field The national survey of sexual attitudes and lifestyles 1994 Blackwell Scientific Press Oxford
44. A.M. Johnson, C.H. Mercer, B. Erens, A.J. Copas, S. McManus, and K. Wellings Sexual behavior in Britain: partnerships, practices, and HIV risk behaviors Lancet 358 2001 1835 1842
45. R.L. Winer, J.P. Hughes, Q. Feng, S. O'Reilly, N.B. Kiviat, and K.K. Holmes Condom use and the risk of genital human papillomavirus infection in young women N Engl J Med 354 2006 2645 2654
46. C.M. Wheeler, C.A. Parmenter, W.C. Hunt, T.M. Becker, C.E. Greer, and A. Hildesheim Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center Sex Transm Dis 20 1993 286 289
47. T.K. Young, P. McNicol, and J. Beauvais Factors associated with human papillomavirus infection detected by polymerase chain reaction among urban Canadian aboriginal and non-aboriginal women Sex Transm Dis 24 1997 293 298
48. A.R. Giuliano, M. Papenfuss, A. Schneider, M. Nour, and K. Hatch Risk factors for high-risk type human papillomavirus infection among Mexican-American women Cancer Epidemiol Biomarkers Prev 8 1999 615 620
49. Paavonen J and the FUTURE II Study Group Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6/11/16/18) vaccine clinical trials Curr Med Res Opin 24 2008 1623 1634
50. M. Stanley Early age of sexual debut: a risky experience J Fam Plann Reprod Health Care 35 2009 118 120
51. A.B. Moscicki HPV infections in adolescents Dis Markers 23 2007 229 234
52. K. Denks, E.L. Spaeth, K. Jõers, R. Randoja, T. Talpsep, and M. Ustav Coinfection of Chlamydia trachomatis, Ureaplasmaurealyticum and human papillomavirus among patients attending STD clinics in Estonia Scand J Infect Dis 39 2007 714 718
53. P. Seth, G.M. Wingood, L.S. Robinson, and R.J. Diclemente Exposure to high-risk genital human papillomavirus and its association with risky sexual practices and laboratory-confirmed chlamydia among African-American women Womens Health Issues 19 2009 344 351
54. A. Nielsen, S.K. Kjaer, C. Munk, and T. Iftner Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women Sex Transm Dis 35 2008 276 282
55. P.E. Castle, and A.R. Giuliano Chapter 4: genital tract infections, cervical inflammation and antioxidant nutrients - assessing their roles as human papillomavirus cofactors J Natl Cancer Inst Monogr 31 2003 29 34
56. I. Silins, W. Ryd, A. Strand, S. Törnberg, B.G. Hansson, and X. Wang Chlamydia trachomatis infection and persistence of human papillomavirus Int J Cancer 116 2005 110 115
57. E. Samoff, E.H. Koumans, L.E. Markowitz, M. Sternberg, M.K. Sawyer, and D. Swan Association of Chlamydia trachomatis with persistence of high risk types of human papillomavirus in a cohort of female adolescents Am J Epidemiol 162 2005 668 675
58. K.-L. Wallin, F. Wiklund, T. Luostarinen, T. Ånström, T. Anttila, and F. Bergman A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma Int J Cancer 101 2002 371 374
59. S. Collins, S. Mazloomzadeh, H. Winter, P. Blomfield, A. Bailey, and L.S. Young High incidence of cervical human papillomavirus infection in women during their first sexual relationship BJOG 109 2002 96 98
60. L.E. Durant, and M.P. Carey Self-administered questionnaires versus face-to-face interviews in assessing sexual behavior in young women Arch Sex Behav 29 2000 309 322
61. J.N. Gribble, H.G. Miller, S.M. Rogers, and C.F. Turner Interview mode and measurement of sexual behaviors: methodological issues J Sex Res 36 1999 16 24
62. N.D. Brener, J.O.G. Billy, and W.R. Grady Assessment of factors affecting the validity of self-reported health-risk behavior among adolescents: evidence from the scientific literature J Adolesc Health 33 2003 436 457